Colon Cancer Information Center
Colon cancer is the fourth most commonly diagnosed cancer in the United States. Each year, approximately 54,000 men and 54,000 women will be diagnosed with colon cancer. To reduce these numbers, researchers continue to explore new approaches to colon cancer prevention. Healthy behaviors such as regular physical activity, for example, have consistently been found to reduce the risk of colon cancer.
Progress is also being made in the early detection and treatment of colon cancer. Screening tests such as colonoscopy allow many cancers to be identified at an early stage, and also allow for the identification and treatment of precancerous polyps. Advances in surgery, chemotherapy, and targeted therapy have also made important contributions to improved colon cancer survival, and it is estimated that there are more than 700,000 colon cancer survivors in the United States today.
Understanding colon cancer treatment options, the role of different doctors specializing in the treatment of colon cancer, and how and when to access new and innovative colon cancer treatment options available through clinical trials is essential in order to achieve the best outcome from colon cancer treatment.
The Cancer Consultants Colon Cancer Information Center has been designed to help patients understand options for colon cancer prevention, early detection, and treatment, while providing ongoing information, inspiration, support, and community to individuals affected by a diagnosis of colon cancer.
Headline Colon Cancer News 
Early Morning Colonoscopies Detect More Polyps
Rate of polyp detection tends to drop over the course of a day.
Excess Weight Linked with More Than 100,000 Cancer Diagnoses Each Year
Increases risk of several types of cancer
Daily Aspirin Prevents Colorectal Cancer in Lynch Syndrome
Long-term use of aspirin benefits individuals with Lynch syndrome.
Colon Cancer Tips
Understanding the Goals of Cancer Treatment with Chemotherapy If you’ve been diagnosed with cancer, your healthcare team may have prescribed...
What to Tell Children when Facing a Diagnosis of Cancer If you have children in your life, you already know that they tend to be creatures...
What You Need to Know About BRCA and Genetic Testing I keep hearing the term breast cancer genes. What does that mean?
Colon Cancer Management
Inspiration, Hope & Resources
The Colon Club Meet an organization defined by out-of-the-box projects that inspire lifesaving...
C3: Colorectal Cancer Coalition Empowering Advocates and Pushing for a Cure by Diana Price Kate Murphy, director...
Care Is Just a Call Away The Colorectal CareLine: Providing Comprehensive Service to Patients in Times of...
Colon Cancer Conference Coverage
ASCO 2009: Updates in the Treatment of Colorectal Cancer Date: May 29 – June 2, 2009 Location: Orlando, Florida Author: Allyson...
Colon Cancer Clinical Trials
E5204 – Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil and Leucovorin vs Oxaliplatin, 5-Fluorouracil, Leucovorin and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Pre-operative chemoradiation
CTSUE5202 – A randomized phase III clinical trial comparing 5-fluorouracil (5-FU), Leucovorin, Oxaliplatin (mFOLFOX6) and Bevacizumab in patients with stage II colon cancer at high risk for recurrence to determine prospectively the prognostic value of molecular markers.
07-141 – A Multi-center, Open-label, Randomized, Phase 2 Clinical Trial Evaluating Safety and Efficacy of FOLFIRI with Either Panitumumab or Bevacizumab as a Second-line Treatment in Subjects with Metastatic Colorectal Cancer
 |
 |
 |
 |
